Skip to main content

Table 1 General patients characteristics

From: High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience

Factor N (%)
Number of patients 11
Age (median) 18–62 (40) years
Gender  
F 6 (55 %)
M 5 (45 %)
SS-m 6 (55 %)
MS 5 (45 %)
Risk organ involvement 5 (45 %)
Lung 4 (36 %)
Spleen 1 (9 %)
Prior therapy 2 (18 %)
Radiotherapy 1 (9 %)
Topical steroids 1 (9 %)
  1. N number, F female, M male, SS-m single system multifocal, MS multisystem
\